✦ LIBER ✦

Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection

✍ Scribed by Mika Kurokawa, Naoki Hiramatsu, Tsugiko Oze, Takayuki Yakushijin, Masanori Miyazaki, Atsushi Hosui, Takuya Miyagi, Yuichi Yoshida, Hisashi Ishida, Tomohide Tatsumi, Shinichi Kiso, Tatsuya Kanto, Akinori Kasahara, Sadaharu Iio, Yoshinori Doi, et al

Book ID: 113046990
Publisher: Springer Japan
Year: 2012
Tongue: English
Weight: 225 KB
Volume: 47
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-011-0522-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term entecavir treatment reduces he

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

✍ Hosaka, Tetsuya; Suzuki, Fumitaka; Kobayashi, Masahiro; Seko, Yuya; Kawamura, Yu 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 765 KB

Long-term incidence of hepatitis B virus

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus–infected patients

✍ Yves Benhamou; Marie Bochet; Vincent Thibault; Vincent Di Martino; Eric Caumes; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

Hepatitis B virus (HBV) resistance to lamivudine has not been extensively documented in human immunodeficiency virus (HIV)-infected patients. We studied the long-term incidence of HBV resistance to lamivudine in HIV-positive patients. Sixty-six HIV-HBV-coinfected patients were studied while receivin

Response to long-term lamivudine treatme

Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C

✍ Mariko Kobayashi; Fumitaka Suzuki; Norio Akuta; Yoshiyuki Suzuki; Yasuji Arase; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

## Abstract Response to lamivudine treatment longer than 1 year was compared in 15 patients persistently infected with hepatitis B virus (HBV) genotype A, 38 with genotype B, and 449 with genotype C. Patients with genotype A were younger (median age 37 [range 24–49] vs. 47 [24–67] or 44 [18–73], __

Long term treatment with lamivudine and

Long term treatment with lamivudine and incidence of hepatocellular carcinoma (HCC) in HBV-related cirrhosis

✍ V. Di Marco; D. Ferraro; C. Bonura; P. Parisi; L. Sandonato; M. Cappello; P. Alm 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Long-term safety of lamivudine treatment

Long-term safety of lamivudine treatment in patients with chronic hepatitis B

✍ Anna S.F Lok; Ching-Lung Lai; Nancy Leung; Guang-Bi Yao; Zhen-Yu Cui; Eugene R S 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Association of hepatitis b virus infecti

Association of hepatitis b virus infection with hepatocellular carcinoma in american patients

✍ Robert L. Yarrish; Barbara G. Werner; Baruch S. Blumberg 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 503 KB

## Abstract Thirty‐four patients from the Philadelphia area with hepatocellular carcinoma (HCC) were matched with colon cancer patients, lung cancer patients and blood donors according to age and sex. Sera from the four groups were tested to determine the prevalence of hepatitis B surface antigen (